| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |